Global Vaccine Excipients Market Growth 2026-2032
The global Vaccine Excipients market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
The manufacture and composition of vaccines are complex and are strictly regulated to maximize potency and safety. In addition to antigens, vaccines also contain some important substances—vaccine excipients. Vaccine excipients comprise all chemical compounds used in the production of vaccines, such as vaccine stabilizers, vaccine emulsifiers, preservatives and vaccine adjuvants.
United States market for Vaccine Excipients is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Vaccine Excipients is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Vaccine Excipients is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Vaccine Excipients players cover Curia, Croda Pharma, Alfa Chemistry, A & C, Avantor, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Vaccine Excipients Industry Forecast” looks at past sales and reviews total world Vaccine Excipients sales in 2025, providing a comprehensive analysis by region and market sector of projected Vaccine Excipients sales for 2026 through 2032. With Vaccine Excipients sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vaccine Excipients industry.
This Insight Report provides a comprehensive analysis of the global Vaccine Excipients landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vaccine Excipients portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Vaccine Excipients market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vaccine Excipients and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vaccine Excipients.
This report presents a comprehensive overview, market shares, and growth opportunities of Vaccine Excipients market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
The manufacture and composition of vaccines are complex and are strictly regulated to maximize potency and safety. In addition to antigens, vaccines also contain some important substances—vaccine excipients. Vaccine excipients comprise all chemical compounds used in the production of vaccines, such as vaccine stabilizers, vaccine emulsifiers, preservatives and vaccine adjuvants.
United States market for Vaccine Excipients is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Vaccine Excipients is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Vaccine Excipients is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Vaccine Excipients players cover Curia, Croda Pharma, Alfa Chemistry, A & C, Avantor, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Vaccine Excipients Industry Forecast” looks at past sales and reviews total world Vaccine Excipients sales in 2025, providing a comprehensive analysis by region and market sector of projected Vaccine Excipients sales for 2026 through 2032. With Vaccine Excipients sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vaccine Excipients industry.
This Insight Report provides a comprehensive analysis of the global Vaccine Excipients landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vaccine Excipients portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Vaccine Excipients market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vaccine Excipients and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vaccine Excipients.
This report presents a comprehensive overview, market shares, and growth opportunities of Vaccine Excipients market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Vaccine Stabilizers
- Vaccine Emulsifiers
- Vaccine Adjuvants
- Preservatives
- Research Applications
- Commercial Applications
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Curia
- Croda Pharma
- Alfa Chemistry
- A & C
- Avantor
- GS
- SEPPIC
- Novavax
- Dynavax Technologies
- Sanofi
- Zhifei Biological
- Escon
- Rico Bio
- CSL Limited
- Creative Biolabs
- Central Drug House
- What is the 10-year outlook for the global Vaccine Excipients market?
- What factors are driving Vaccine Excipients market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Vaccine Excipients market opportunities vary by end market size?
- How does Vaccine Excipients break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vaccine Excipients Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Vaccine Excipients by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Vaccine Excipients by Country/Region, 2021, 2025 & 2032
2.2 Vaccine Excipients Segment by Type
2.2.1 Vaccine Stabilizers
2.2.2 Vaccine Emulsifiers
2.2.3 Vaccine Adjuvants
2.2.4 Preservatives
2.2.5 Vaccine Excipients Sales by Type
2.2.5.1 Global Vaccine Excipients Sales Market Share by Type (2021-2026)
2.2.5.2 Global Vaccine Excipients Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Vaccine Excipients Sale Price by Type (2021-2026)
2.3 Vaccine Excipients Segment by Application
2.3.1 Research Applications
2.3.2 Commercial Applications
2.3.3 Vaccine Excipients Sales by Application
2.3.3.1 Global Vaccine Excipients Sale Market Share by Application (2021-2026)
2.3.3.2 Global Vaccine Excipients Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Vaccine Excipients Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Vaccine Excipients Breakdown Data by Company
3.1.1 Global Vaccine Excipients Annual Sales by Company (2021-2026)
3.1.2 Global Vaccine Excipients Sales Market Share by Company (2021-2026)
3.2 Global Vaccine Excipients Annual Revenue by Company (2021-2026)
3.2.1 Global Vaccine Excipients Revenue by Company (2021-2026)
3.2.2 Global Vaccine Excipients Revenue Market Share by Company (2021-2026)
3.3 Global Vaccine Excipients Sale Price by Company
3.4 Key Manufacturers Vaccine Excipients Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vaccine Excipients Product Location Distribution
3.4.2 Players Vaccine Excipients Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VACCINE EXCIPIENTS BY GEOGRAPHIC REGION
4.1 World Historic Vaccine Excipients Market Size by Geographic Region (2021-2026)
4.1.1 Global Vaccine Excipients Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Vaccine Excipients Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Vaccine Excipients Market Size by Country/Region (2021-2026)
4.2.1 Global Vaccine Excipients Annual Sales by Country/Region (2021-2026)
4.2.2 Global Vaccine Excipients Annual Revenue by Country/Region (2021-2026)
4.3 Americas Vaccine Excipients Sales Growth
4.4 APAC Vaccine Excipients Sales Growth
4.5 Europe Vaccine Excipients Sales Growth
4.6 Middle East & Africa Vaccine Excipients Sales Growth
5 AMERICAS
5.1 Americas Vaccine Excipients Sales by Country
5.1.1 Americas Vaccine Excipients Sales by Country (2021-2026)
5.1.2 Americas Vaccine Excipients Revenue by Country (2021-2026)
5.2 Americas Vaccine Excipients Sales by Type (2021-2026)
5.3 Americas Vaccine Excipients Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vaccine Excipients Sales by Region
6.1.1 APAC Vaccine Excipients Sales by Region (2021-2026)
6.1.2 APAC Vaccine Excipients Revenue by Region (2021-2026)
6.2 APAC Vaccine Excipients Sales by Type (2021-2026)
6.3 APAC Vaccine Excipients Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Vaccine Excipients by Country
7.1.1 Europe Vaccine Excipients Sales by Country (2021-2026)
7.1.2 Europe Vaccine Excipients Revenue by Country (2021-2026)
7.2 Europe Vaccine Excipients Sales by Type (2021-2026)
7.3 Europe Vaccine Excipients Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vaccine Excipients by Country
8.1.1 Middle East & Africa Vaccine Excipients Sales by Country (2021-2026)
8.1.2 Middle East & Africa Vaccine Excipients Revenue by Country (2021-2026)
8.2 Middle East & Africa Vaccine Excipients Sales by Type (2021-2026)
8.3 Middle East & Africa Vaccine Excipients Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vaccine Excipients
10.3 Manufacturing Process Analysis of Vaccine Excipients
10.4 Industry Chain Structure of Vaccine Excipients
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vaccine Excipients Distributors
11.3 Vaccine Excipients Customer
12 WORLD FORECAST REVIEW FOR VACCINE EXCIPIENTS BY GEOGRAPHIC REGION
12.1 Global Vaccine Excipients Market Size Forecast by Region
12.1.1 Global Vaccine Excipients Forecast by Region (2027-2032)
12.1.2 Global Vaccine Excipients Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Vaccine Excipients Forecast by Type (2027-2032)
12.7 Global Vaccine Excipients Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Curia
13.1.1 Curia Company Information
13.1.2 Curia Vaccine Excipients Product Portfolios and Specifications
13.1.3 Curia Vaccine Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Curia Main Business Overview
13.1.5 Curia Latest Developments
13.2 Croda Pharma
13.2.1 Croda Pharma Company Information
13.2.2 Croda Pharma Vaccine Excipients Product Portfolios and Specifications
13.2.3 Croda Pharma Vaccine Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Croda Pharma Main Business Overview
13.2.5 Croda Pharma Latest Developments
13.3 Alfa Chemistry
13.3.1 Alfa Chemistry Company Information
13.3.2 Alfa Chemistry Vaccine Excipients Product Portfolios and Specifications
13.3.3 Alfa Chemistry Vaccine Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Alfa Chemistry Main Business Overview
13.3.5 Alfa Chemistry Latest Developments
13.4 A & C
13.4.1 A & C Company Information
13.4.2 A & C Vaccine Excipients Product Portfolios and Specifications
13.4.3 A & C Vaccine Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 A & C Main Business Overview
13.4.5 A & C Latest Developments
13.5 Avantor
13.5.1 Avantor Company Information
13.5.2 Avantor Vaccine Excipients Product Portfolios and Specifications
13.5.3 Avantor Vaccine Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Avantor Main Business Overview
13.5.5 Avantor Latest Developments
13.6 GS
13.6.1 GS Company Information
13.6.2 GS Vaccine Excipients Product Portfolios and Specifications
13.6.3 GS Vaccine Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 GS Main Business Overview
13.6.5 GS Latest Developments
13.7 SEPPIC
13.7.1 SEPPIC Company Information
13.7.2 SEPPIC Vaccine Excipients Product Portfolios and Specifications
13.7.3 SEPPIC Vaccine Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 SEPPIC Main Business Overview
13.7.5 SEPPIC Latest Developments
13.8 Novavax
13.8.1 Novavax Company Information
13.8.2 Novavax Vaccine Excipients Product Portfolios and Specifications
13.8.3 Novavax Vaccine Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Novavax Main Business Overview
13.8.5 Novavax Latest Developments
13.9 Dynavax Technologies
13.9.1 Dynavax Technologies Company Information
13.9.2 Dynavax Technologies Vaccine Excipients Product Portfolios and Specifications
13.9.3 Dynavax Technologies Vaccine Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Dynavax Technologies Main Business Overview
13.9.5 Dynavax Technologies Latest Developments
13.10 Sanofi
13.10.1 Sanofi Company Information
13.10.2 Sanofi Vaccine Excipients Product Portfolios and Specifications
13.10.3 Sanofi Vaccine Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Sanofi Main Business Overview
13.10.5 Sanofi Latest Developments
13.11 Zhifei Biological
13.11.1 Zhifei Biological Company Information
13.11.2 Zhifei Biological Vaccine Excipients Product Portfolios and Specifications
13.11.3 Zhifei Biological Vaccine Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Zhifei Biological Main Business Overview
13.11.5 Zhifei Biological Latest Developments
13.12 Escon
13.12.1 Escon Company Information
13.12.2 Escon Vaccine Excipients Product Portfolios and Specifications
13.12.3 Escon Vaccine Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Escon Main Business Overview
13.12.5 Escon Latest Developments
13.13 Rico Bio
13.13.1 Rico Bio Company Information
13.13.2 Rico Bio Vaccine Excipients Product Portfolios and Specifications
13.13.3 Rico Bio Vaccine Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Rico Bio Main Business Overview
13.13.5 Rico Bio Latest Developments
13.14 CSL Limited
13.14.1 CSL Limited Company Information
13.14.2 CSL Limited Vaccine Excipients Product Portfolios and Specifications
13.14.3 CSL Limited Vaccine Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 CSL Limited Main Business Overview
13.14.5 CSL Limited Latest Developments
13.15 Creative Biolabs
13.15.1 Creative Biolabs Company Information
13.15.2 Creative Biolabs Vaccine Excipients Product Portfolios and Specifications
13.15.3 Creative Biolabs Vaccine Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Creative Biolabs Main Business Overview
13.15.5 Creative Biolabs Latest Developments
13.16 Central Drug House
13.16.1 Central Drug House Company Information
13.16.2 Central Drug House Vaccine Excipients Product Portfolios and Specifications
13.16.3 Central Drug House Vaccine Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Central Drug House Main Business Overview
13.16.5 Central Drug House Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vaccine Excipients Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Vaccine Excipients by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Vaccine Excipients by Country/Region, 2021, 2025 & 2032
2.2 Vaccine Excipients Segment by Type
2.2.1 Vaccine Stabilizers
2.2.2 Vaccine Emulsifiers
2.2.3 Vaccine Adjuvants
2.2.4 Preservatives
2.2.5 Vaccine Excipients Sales by Type
2.2.5.1 Global Vaccine Excipients Sales Market Share by Type (2021-2026)
2.2.5.2 Global Vaccine Excipients Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Vaccine Excipients Sale Price by Type (2021-2026)
2.3 Vaccine Excipients Segment by Application
2.3.1 Research Applications
2.3.2 Commercial Applications
2.3.3 Vaccine Excipients Sales by Application
2.3.3.1 Global Vaccine Excipients Sale Market Share by Application (2021-2026)
2.3.3.2 Global Vaccine Excipients Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Vaccine Excipients Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Vaccine Excipients Breakdown Data by Company
3.1.1 Global Vaccine Excipients Annual Sales by Company (2021-2026)
3.1.2 Global Vaccine Excipients Sales Market Share by Company (2021-2026)
3.2 Global Vaccine Excipients Annual Revenue by Company (2021-2026)
3.2.1 Global Vaccine Excipients Revenue by Company (2021-2026)
3.2.2 Global Vaccine Excipients Revenue Market Share by Company (2021-2026)
3.3 Global Vaccine Excipients Sale Price by Company
3.4 Key Manufacturers Vaccine Excipients Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vaccine Excipients Product Location Distribution
3.4.2 Players Vaccine Excipients Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VACCINE EXCIPIENTS BY GEOGRAPHIC REGION
4.1 World Historic Vaccine Excipients Market Size by Geographic Region (2021-2026)
4.1.1 Global Vaccine Excipients Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Vaccine Excipients Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Vaccine Excipients Market Size by Country/Region (2021-2026)
4.2.1 Global Vaccine Excipients Annual Sales by Country/Region (2021-2026)
4.2.2 Global Vaccine Excipients Annual Revenue by Country/Region (2021-2026)
4.3 Americas Vaccine Excipients Sales Growth
4.4 APAC Vaccine Excipients Sales Growth
4.5 Europe Vaccine Excipients Sales Growth
4.6 Middle East & Africa Vaccine Excipients Sales Growth
5 AMERICAS
5.1 Americas Vaccine Excipients Sales by Country
5.1.1 Americas Vaccine Excipients Sales by Country (2021-2026)
5.1.2 Americas Vaccine Excipients Revenue by Country (2021-2026)
5.2 Americas Vaccine Excipients Sales by Type (2021-2026)
5.3 Americas Vaccine Excipients Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vaccine Excipients Sales by Region
6.1.1 APAC Vaccine Excipients Sales by Region (2021-2026)
6.1.2 APAC Vaccine Excipients Revenue by Region (2021-2026)
6.2 APAC Vaccine Excipients Sales by Type (2021-2026)
6.3 APAC Vaccine Excipients Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Vaccine Excipients by Country
7.1.1 Europe Vaccine Excipients Sales by Country (2021-2026)
7.1.2 Europe Vaccine Excipients Revenue by Country (2021-2026)
7.2 Europe Vaccine Excipients Sales by Type (2021-2026)
7.3 Europe Vaccine Excipients Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vaccine Excipients by Country
8.1.1 Middle East & Africa Vaccine Excipients Sales by Country (2021-2026)
8.1.2 Middle East & Africa Vaccine Excipients Revenue by Country (2021-2026)
8.2 Middle East & Africa Vaccine Excipients Sales by Type (2021-2026)
8.3 Middle East & Africa Vaccine Excipients Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vaccine Excipients
10.3 Manufacturing Process Analysis of Vaccine Excipients
10.4 Industry Chain Structure of Vaccine Excipients
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vaccine Excipients Distributors
11.3 Vaccine Excipients Customer
12 WORLD FORECAST REVIEW FOR VACCINE EXCIPIENTS BY GEOGRAPHIC REGION
12.1 Global Vaccine Excipients Market Size Forecast by Region
12.1.1 Global Vaccine Excipients Forecast by Region (2027-2032)
12.1.2 Global Vaccine Excipients Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Vaccine Excipients Forecast by Type (2027-2032)
12.7 Global Vaccine Excipients Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Curia
13.1.1 Curia Company Information
13.1.2 Curia Vaccine Excipients Product Portfolios and Specifications
13.1.3 Curia Vaccine Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Curia Main Business Overview
13.1.5 Curia Latest Developments
13.2 Croda Pharma
13.2.1 Croda Pharma Company Information
13.2.2 Croda Pharma Vaccine Excipients Product Portfolios and Specifications
13.2.3 Croda Pharma Vaccine Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Croda Pharma Main Business Overview
13.2.5 Croda Pharma Latest Developments
13.3 Alfa Chemistry
13.3.1 Alfa Chemistry Company Information
13.3.2 Alfa Chemistry Vaccine Excipients Product Portfolios and Specifications
13.3.3 Alfa Chemistry Vaccine Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Alfa Chemistry Main Business Overview
13.3.5 Alfa Chemistry Latest Developments
13.4 A & C
13.4.1 A & C Company Information
13.4.2 A & C Vaccine Excipients Product Portfolios and Specifications
13.4.3 A & C Vaccine Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 A & C Main Business Overview
13.4.5 A & C Latest Developments
13.5 Avantor
13.5.1 Avantor Company Information
13.5.2 Avantor Vaccine Excipients Product Portfolios and Specifications
13.5.3 Avantor Vaccine Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Avantor Main Business Overview
13.5.5 Avantor Latest Developments
13.6 GS
13.6.1 GS Company Information
13.6.2 GS Vaccine Excipients Product Portfolios and Specifications
13.6.3 GS Vaccine Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 GS Main Business Overview
13.6.5 GS Latest Developments
13.7 SEPPIC
13.7.1 SEPPIC Company Information
13.7.2 SEPPIC Vaccine Excipients Product Portfolios and Specifications
13.7.3 SEPPIC Vaccine Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 SEPPIC Main Business Overview
13.7.5 SEPPIC Latest Developments
13.8 Novavax
13.8.1 Novavax Company Information
13.8.2 Novavax Vaccine Excipients Product Portfolios and Specifications
13.8.3 Novavax Vaccine Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Novavax Main Business Overview
13.8.5 Novavax Latest Developments
13.9 Dynavax Technologies
13.9.1 Dynavax Technologies Company Information
13.9.2 Dynavax Technologies Vaccine Excipients Product Portfolios and Specifications
13.9.3 Dynavax Technologies Vaccine Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Dynavax Technologies Main Business Overview
13.9.5 Dynavax Technologies Latest Developments
13.10 Sanofi
13.10.1 Sanofi Company Information
13.10.2 Sanofi Vaccine Excipients Product Portfolios and Specifications
13.10.3 Sanofi Vaccine Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Sanofi Main Business Overview
13.10.5 Sanofi Latest Developments
13.11 Zhifei Biological
13.11.1 Zhifei Biological Company Information
13.11.2 Zhifei Biological Vaccine Excipients Product Portfolios and Specifications
13.11.3 Zhifei Biological Vaccine Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Zhifei Biological Main Business Overview
13.11.5 Zhifei Biological Latest Developments
13.12 Escon
13.12.1 Escon Company Information
13.12.2 Escon Vaccine Excipients Product Portfolios and Specifications
13.12.3 Escon Vaccine Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Escon Main Business Overview
13.12.5 Escon Latest Developments
13.13 Rico Bio
13.13.1 Rico Bio Company Information
13.13.2 Rico Bio Vaccine Excipients Product Portfolios and Specifications
13.13.3 Rico Bio Vaccine Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Rico Bio Main Business Overview
13.13.5 Rico Bio Latest Developments
13.14 CSL Limited
13.14.1 CSL Limited Company Information
13.14.2 CSL Limited Vaccine Excipients Product Portfolios and Specifications
13.14.3 CSL Limited Vaccine Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 CSL Limited Main Business Overview
13.14.5 CSL Limited Latest Developments
13.15 Creative Biolabs
13.15.1 Creative Biolabs Company Information
13.15.2 Creative Biolabs Vaccine Excipients Product Portfolios and Specifications
13.15.3 Creative Biolabs Vaccine Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Creative Biolabs Main Business Overview
13.15.5 Creative Biolabs Latest Developments
13.16 Central Drug House
13.16.1 Central Drug House Company Information
13.16.2 Central Drug House Vaccine Excipients Product Portfolios and Specifications
13.16.3 Central Drug House Vaccine Excipients Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Central Drug House Main Business Overview
13.16.5 Central Drug House Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Vaccine Excipients Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Vaccine Excipients Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Vaccine Stabilizers
Table 4. Major Players of Vaccine Emulsifiers
Table 5. Major Players of Vaccine Adjuvants
Table 6. Major Players of Preservatives
Table 7. Global Vaccine Excipients Sales by Type (2021-2026) & (kg)
Table 8. Global Vaccine Excipients Sales Market Share by Type (2021-2026)
Table 9. Global Vaccine Excipients Revenue by Type (2021-2026) & ($ million)
Table 10. Global Vaccine Excipients Revenue Market Share by Type (2021-2026)
Table 11. Global Vaccine Excipients Sale Price by Type (2021-2026) & (US$/g)
Table 12. Global Vaccine Excipients Sale by Application (2021-2026) & (kg)
Table 13. Global Vaccine Excipients Sale Market Share by Application (2021-2026)
Table 14. Global Vaccine Excipients Revenue by Application (2021-2026) & ($ million)
Table 15. Global Vaccine Excipients Revenue Market Share by Application (2021-2026)
Table 16. Global Vaccine Excipients Sale Price by Application (2021-2026) & (US$/g)
Table 17. Global Vaccine Excipients Sales by Company (2021-2026) & (kg)
Table 18. Global Vaccine Excipients Sales Market Share by Company (2021-2026)
Table 19. Global Vaccine Excipients Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Vaccine Excipients Revenue Market Share by Company (2021-2026)
Table 21. Global Vaccine Excipients Sale Price by Company (2021-2026) & (US$/g)
Table 22. Key Manufacturers Vaccine Excipients Producing Area Distribution and Sales Area
Table 23. Players Vaccine Excipients Products Offered
Table 24. Vaccine Excipients Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Vaccine Excipients Sales by Geographic Region (2021-2026) & (kg)
Table 28. Global Vaccine Excipients Sales Market Share Geographic Region (2021-2026)
Table 29. Global Vaccine Excipients Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Vaccine Excipients Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Vaccine Excipients Sales by Country/Region (2021-2026) & (kg)
Table 32. Global Vaccine Excipients Sales Market Share by Country/Region (2021-2026)
Table 33. Global Vaccine Excipients Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Vaccine Excipients Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Vaccine Excipients Sales by Country (2021-2026) & (kg)
Table 36. Americas Vaccine Excipients Sales Market Share by Country (2021-2026)
Table 37. Americas Vaccine Excipients Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Vaccine Excipients Sales by Type (2021-2026) & (kg)
Table 39. Americas Vaccine Excipients Sales by Application (2021-2026) & (kg)
Table 40. APAC Vaccine Excipients Sales by Region (2021-2026) & (kg)
Table 41. APAC Vaccine Excipients Sales Market Share by Region (2021-2026)
Table 42. APAC Vaccine Excipients Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Vaccine Excipients Sales by Type (2021-2026) & (kg)
Table 44. APAC Vaccine Excipients Sales by Application (2021-2026) & (kg)
Table 45. Europe Vaccine Excipients Sales by Country (2021-2026) & (kg)
Table 46. Europe Vaccine Excipients Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Vaccine Excipients Sales by Type (2021-2026) & (kg)
Table 48. Europe Vaccine Excipients Sales by Application (2021-2026) & (kg)
Table 49. Middle East & Africa Vaccine Excipients Sales by Country (2021-2026) & (kg)
Table 50. Middle East & Africa Vaccine Excipients Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Vaccine Excipients Sales by Type (2021-2026) & (kg)
Table 52. Middle East & Africa Vaccine Excipients Sales by Application (2021-2026) & (kg)
Table 53. Key Market Drivers & Growth Opportunities of Vaccine Excipients
Table 54. Key Market Challenges & Risks of Vaccine Excipients
Table 55. Key Industry Trends of Vaccine Excipients
Table 56. Vaccine Excipients Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Vaccine Excipients Distributors List
Table 59. Vaccine Excipients Customer List
Table 60. Global Vaccine Excipients Sales Forecast by Region (2027-2032) & (kg)
Table 61. Global Vaccine Excipients Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Vaccine Excipients Sales Forecast by Country (2027-2032) & (kg)
Table 63. Americas Vaccine Excipients Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Vaccine Excipients Sales Forecast by Region (2027-2032) & (kg)
Table 65. APAC Vaccine Excipients Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Vaccine Excipients Sales Forecast by Country (2027-2032) & (kg)
Table 67. Europe Vaccine Excipients Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Vaccine Excipients Sales Forecast by Country (2027-2032) & (kg)
Table 69. Middle East & Africa Vaccine Excipients Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Vaccine Excipients Sales Forecast by Type (2027-2032) & (kg)
Table 71. Global Vaccine Excipients Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Vaccine Excipients Sales Forecast by Application (2027-2032) & (kg)
Table 73. Global Vaccine Excipients Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Curia Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 75. Curia Vaccine Excipients Product Portfolios and Specifications
Table 76. Curia Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 77. Curia Main Business
Table 78. Curia Latest Developments
Table 79. Croda Pharma Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 80. Croda Pharma Vaccine Excipients Product Portfolios and Specifications
Table 81. Croda Pharma Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 82. Croda Pharma Main Business
Table 83. Croda Pharma Latest Developments
Table 84. Alfa Chemistry Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 85. Alfa Chemistry Vaccine Excipients Product Portfolios and Specifications
Table 86. Alfa Chemistry Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 87. Alfa Chemistry Main Business
Table 88. Alfa Chemistry Latest Developments
Table 89. A & C Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 90. A & C Vaccine Excipients Product Portfolios and Specifications
Table 91. A & C Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 92. A & C Main Business
Table 93. A & C Latest Developments
Table 94. Avantor Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 95. Avantor Vaccine Excipients Product Portfolios and Specifications
Table 96. Avantor Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 97. Avantor Main Business
Table 98. Avantor Latest Developments
Table 99. GS Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 100. GS Vaccine Excipients Product Portfolios and Specifications
Table 101. GS Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 102. GS Main Business
Table 103. GS Latest Developments
Table 104. SEPPIC Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 105. SEPPIC Vaccine Excipients Product Portfolios and Specifications
Table 106. SEPPIC Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 107. SEPPIC Main Business
Table 108. SEPPIC Latest Developments
Table 109. Novavax Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 110. Novavax Vaccine Excipients Product Portfolios and Specifications
Table 111. Novavax Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 112. Novavax Main Business
Table 113. Novavax Latest Developments
Table 114. Dynavax Technologies Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 115. Dynavax Technologies Vaccine Excipients Product Portfolios and Specifications
Table 116. Dynavax Technologies Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 117. Dynavax Technologies Main Business
Table 118. Dynavax Technologies Latest Developments
Table 119. Sanofi Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 120. Sanofi Vaccine Excipients Product Portfolios and Specifications
Table 121. Sanofi Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 122. Sanofi Main Business
Table 123. Sanofi Latest Developments
Table 124. Zhifei Biological Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 125. Zhifei Biological Vaccine Excipients Product Portfolios and Specifications
Table 126. Zhifei Biological Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 127. Zhifei Biological Main Business
Table 128. Zhifei Biological Latest Developments
Table 129. Escon Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 130. Escon Vaccine Excipients Product Portfolios and Specifications
Table 131. Escon Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 132. Escon Main Business
Table 133. Escon Latest Developments
Table 134. Rico Bio Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 135. Rico Bio Vaccine Excipients Product Portfolios and Specifications
Table 136. Rico Bio Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 137. Rico Bio Main Business
Table 138. Rico Bio Latest Developments
Table 139. CSL Limited Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 140. CSL Limited Vaccine Excipients Product Portfolios and Specifications
Table 141. CSL Limited Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 142. CSL Limited Main Business
Table 143. CSL Limited Latest Developments
Table 144. Creative Biolabs Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 145. Creative Biolabs Vaccine Excipients Product Portfolios and Specifications
Table 146. Creative Biolabs Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 147. Creative Biolabs Main Business
Table 148. Creative Biolabs Latest Developments
Table 149. Central Drug House Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 150. Central Drug House Vaccine Excipients Product Portfolios and Specifications
Table 151. Central Drug House Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 152. Central Drug House Main Business
Table 153. Central Drug House Latest Developments
Table 1. Vaccine Excipients Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Vaccine Excipients Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Vaccine Stabilizers
Table 4. Major Players of Vaccine Emulsifiers
Table 5. Major Players of Vaccine Adjuvants
Table 6. Major Players of Preservatives
Table 7. Global Vaccine Excipients Sales by Type (2021-2026) & (kg)
Table 8. Global Vaccine Excipients Sales Market Share by Type (2021-2026)
Table 9. Global Vaccine Excipients Revenue by Type (2021-2026) & ($ million)
Table 10. Global Vaccine Excipients Revenue Market Share by Type (2021-2026)
Table 11. Global Vaccine Excipients Sale Price by Type (2021-2026) & (US$/g)
Table 12. Global Vaccine Excipients Sale by Application (2021-2026) & (kg)
Table 13. Global Vaccine Excipients Sale Market Share by Application (2021-2026)
Table 14. Global Vaccine Excipients Revenue by Application (2021-2026) & ($ million)
Table 15. Global Vaccine Excipients Revenue Market Share by Application (2021-2026)
Table 16. Global Vaccine Excipients Sale Price by Application (2021-2026) & (US$/g)
Table 17. Global Vaccine Excipients Sales by Company (2021-2026) & (kg)
Table 18. Global Vaccine Excipients Sales Market Share by Company (2021-2026)
Table 19. Global Vaccine Excipients Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Vaccine Excipients Revenue Market Share by Company (2021-2026)
Table 21. Global Vaccine Excipients Sale Price by Company (2021-2026) & (US$/g)
Table 22. Key Manufacturers Vaccine Excipients Producing Area Distribution and Sales Area
Table 23. Players Vaccine Excipients Products Offered
Table 24. Vaccine Excipients Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Vaccine Excipients Sales by Geographic Region (2021-2026) & (kg)
Table 28. Global Vaccine Excipients Sales Market Share Geographic Region (2021-2026)
Table 29. Global Vaccine Excipients Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Vaccine Excipients Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Vaccine Excipients Sales by Country/Region (2021-2026) & (kg)
Table 32. Global Vaccine Excipients Sales Market Share by Country/Region (2021-2026)
Table 33. Global Vaccine Excipients Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Vaccine Excipients Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Vaccine Excipients Sales by Country (2021-2026) & (kg)
Table 36. Americas Vaccine Excipients Sales Market Share by Country (2021-2026)
Table 37. Americas Vaccine Excipients Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Vaccine Excipients Sales by Type (2021-2026) & (kg)
Table 39. Americas Vaccine Excipients Sales by Application (2021-2026) & (kg)
Table 40. APAC Vaccine Excipients Sales by Region (2021-2026) & (kg)
Table 41. APAC Vaccine Excipients Sales Market Share by Region (2021-2026)
Table 42. APAC Vaccine Excipients Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Vaccine Excipients Sales by Type (2021-2026) & (kg)
Table 44. APAC Vaccine Excipients Sales by Application (2021-2026) & (kg)
Table 45. Europe Vaccine Excipients Sales by Country (2021-2026) & (kg)
Table 46. Europe Vaccine Excipients Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Vaccine Excipients Sales by Type (2021-2026) & (kg)
Table 48. Europe Vaccine Excipients Sales by Application (2021-2026) & (kg)
Table 49. Middle East & Africa Vaccine Excipients Sales by Country (2021-2026) & (kg)
Table 50. Middle East & Africa Vaccine Excipients Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Vaccine Excipients Sales by Type (2021-2026) & (kg)
Table 52. Middle East & Africa Vaccine Excipients Sales by Application (2021-2026) & (kg)
Table 53. Key Market Drivers & Growth Opportunities of Vaccine Excipients
Table 54. Key Market Challenges & Risks of Vaccine Excipients
Table 55. Key Industry Trends of Vaccine Excipients
Table 56. Vaccine Excipients Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Vaccine Excipients Distributors List
Table 59. Vaccine Excipients Customer List
Table 60. Global Vaccine Excipients Sales Forecast by Region (2027-2032) & (kg)
Table 61. Global Vaccine Excipients Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Vaccine Excipients Sales Forecast by Country (2027-2032) & (kg)
Table 63. Americas Vaccine Excipients Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Vaccine Excipients Sales Forecast by Region (2027-2032) & (kg)
Table 65. APAC Vaccine Excipients Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Vaccine Excipients Sales Forecast by Country (2027-2032) & (kg)
Table 67. Europe Vaccine Excipients Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Vaccine Excipients Sales Forecast by Country (2027-2032) & (kg)
Table 69. Middle East & Africa Vaccine Excipients Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Vaccine Excipients Sales Forecast by Type (2027-2032) & (kg)
Table 71. Global Vaccine Excipients Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Vaccine Excipients Sales Forecast by Application (2027-2032) & (kg)
Table 73. Global Vaccine Excipients Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Curia Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 75. Curia Vaccine Excipients Product Portfolios and Specifications
Table 76. Curia Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 77. Curia Main Business
Table 78. Curia Latest Developments
Table 79. Croda Pharma Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 80. Croda Pharma Vaccine Excipients Product Portfolios and Specifications
Table 81. Croda Pharma Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 82. Croda Pharma Main Business
Table 83. Croda Pharma Latest Developments
Table 84. Alfa Chemistry Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 85. Alfa Chemistry Vaccine Excipients Product Portfolios and Specifications
Table 86. Alfa Chemistry Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 87. Alfa Chemistry Main Business
Table 88. Alfa Chemistry Latest Developments
Table 89. A & C Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 90. A & C Vaccine Excipients Product Portfolios and Specifications
Table 91. A & C Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 92. A & C Main Business
Table 93. A & C Latest Developments
Table 94. Avantor Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 95. Avantor Vaccine Excipients Product Portfolios and Specifications
Table 96. Avantor Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 97. Avantor Main Business
Table 98. Avantor Latest Developments
Table 99. GS Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 100. GS Vaccine Excipients Product Portfolios and Specifications
Table 101. GS Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 102. GS Main Business
Table 103. GS Latest Developments
Table 104. SEPPIC Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 105. SEPPIC Vaccine Excipients Product Portfolios and Specifications
Table 106. SEPPIC Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 107. SEPPIC Main Business
Table 108. SEPPIC Latest Developments
Table 109. Novavax Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 110. Novavax Vaccine Excipients Product Portfolios and Specifications
Table 111. Novavax Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 112. Novavax Main Business
Table 113. Novavax Latest Developments
Table 114. Dynavax Technologies Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 115. Dynavax Technologies Vaccine Excipients Product Portfolios and Specifications
Table 116. Dynavax Technologies Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 117. Dynavax Technologies Main Business
Table 118. Dynavax Technologies Latest Developments
Table 119. Sanofi Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 120. Sanofi Vaccine Excipients Product Portfolios and Specifications
Table 121. Sanofi Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 122. Sanofi Main Business
Table 123. Sanofi Latest Developments
Table 124. Zhifei Biological Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 125. Zhifei Biological Vaccine Excipients Product Portfolios and Specifications
Table 126. Zhifei Biological Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 127. Zhifei Biological Main Business
Table 128. Zhifei Biological Latest Developments
Table 129. Escon Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 130. Escon Vaccine Excipients Product Portfolios and Specifications
Table 131. Escon Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 132. Escon Main Business
Table 133. Escon Latest Developments
Table 134. Rico Bio Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 135. Rico Bio Vaccine Excipients Product Portfolios and Specifications
Table 136. Rico Bio Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 137. Rico Bio Main Business
Table 138. Rico Bio Latest Developments
Table 139. CSL Limited Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 140. CSL Limited Vaccine Excipients Product Portfolios and Specifications
Table 141. CSL Limited Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 142. CSL Limited Main Business
Table 143. CSL Limited Latest Developments
Table 144. Creative Biolabs Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 145. Creative Biolabs Vaccine Excipients Product Portfolios and Specifications
Table 146. Creative Biolabs Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 147. Creative Biolabs Main Business
Table 148. Creative Biolabs Latest Developments
Table 149. Central Drug House Basic Information, Vaccine Excipients Manufacturing Base, Sales Area and Its Competitors
Table 150. Central Drug House Vaccine Excipients Product Portfolios and Specifications
Table 151. Central Drug House Vaccine Excipients Sales (kg), Revenue ($ Million), Price (US$/g) and Gross Margin (2021-2026)
Table 152. Central Drug House Main Business
Table 153. Central Drug House Latest Developments
LIST OF FIGURES
Figure 1. Picture of Vaccine Excipients
Figure 2. Vaccine Excipients Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vaccine Excipients Sales Growth Rate 2021-2032 (kg)
Figure 7. Global Vaccine Excipients Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Vaccine Excipients Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Vaccine Excipients Sales Market Share by Country/Region (2025)
Figure 10. Vaccine Excipients Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Vaccine Stabilizers
Figure 12. Product Picture of Vaccine Emulsifiers
Figure 13. Product Picture of Vaccine Adjuvants
Figure 14. Product Picture of Preservatives
Figure 15. Global Vaccine Excipients Sales Market Share by Type in 2026
Figure 16. Global Vaccine Excipients Revenue Market Share by Type (2021-2026)
Figure 17. Vaccine Excipients Consumed in Research Applications
Figure 18. Global Vaccine Excipients Market: Research Applications (2021-2026) & (kg)
Figure 19. Vaccine Excipients Consumed in Commercial Applications
Figure 20. Global Vaccine Excipients Market: Commercial Applications (2021-2026) & (kg)
Figure 21. Global Vaccine Excipients Sale Market Share by Application (2025)
Figure 22. Global Vaccine Excipients Revenue Market Share by Application in 2026
Figure 23. Vaccine Excipients Sales by Company in 2026 (kg)
Figure 24. Global Vaccine Excipients Sales Market Share by Company in 2026
Figure 25. Vaccine Excipients Revenue by Company in 2026 ($ millions)
Figure 26. Global Vaccine Excipients Revenue Market Share by Company in 2026
Figure 27. Global Vaccine Excipients Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Vaccine Excipients Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Vaccine Excipients Sales 2021-2026 (kg)
Figure 30. Americas Vaccine Excipients Revenue 2021-2026 ($ millions)
Figure 31. APAC Vaccine Excipients Sales 2021-2026 (kg)
Figure 32. APAC Vaccine Excipients Revenue 2021-2026 ($ millions)
Figure 33. Europe Vaccine Excipients Sales 2021-2026 (kg)
Figure 34. Europe Vaccine Excipients Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Vaccine Excipients Sales 2021-2026 (kg)
Figure 36. Middle East & Africa Vaccine Excipients Revenue 2021-2026 ($ millions)
Figure 37. Americas Vaccine Excipients Sales Market Share by Country in 2026
Figure 38. Americas Vaccine Excipients Revenue Market Share by Country (2021-2026)
Figure 39. Americas Vaccine Excipients Sales Market Share by Type (2021-2026)
Figure 40. Americas Vaccine Excipients Sales Market Share by Application (2021-2026)
Figure 41. United States Vaccine Excipients Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Vaccine Excipients Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Vaccine Excipients Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Vaccine Excipients Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Vaccine Excipients Sales Market Share by Region in 2026
Figure 46. APAC Vaccine Excipients Revenue Market Share by Region (2021-2026)
Figure 47. APAC Vaccine Excipients Sales Market Share by Type (2021-2026)
Figure 48. APAC Vaccine Excipients Sales Market Share by Application (2021-2026)
Figure 49. China Vaccine Excipients Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Vaccine Excipients Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Vaccine Excipients Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Vaccine Excipients Revenue Growth 2021-2026 ($ millions)
Figure 53. India Vaccine Excipients Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Vaccine Excipients Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Vaccine Excipients Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Vaccine Excipients Sales Market Share by Country in 2026
Figure 57. Europe Vaccine Excipients Revenue Market Share by Country (2021-2026)
Figure 58. Europe Vaccine Excipients Sales Market Share by Type (2021-2026)
Figure 59. Europe Vaccine Excipients Sales Market Share by Application (2021-2026)
Figure 60. Germany Vaccine Excipients Revenue Growth 2021-2026 ($ millions)
Figure 61. France Vaccine Excipients Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Vaccine Excipients Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Vaccine Excipients Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Vaccine Excipients Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Vaccine Excipients Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Vaccine Excipients Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Vaccine Excipients Sales Market Share by Application (2021-2026)
Figure 68. Egypt Vaccine Excipients Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Vaccine Excipients Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Vaccine Excipients Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Vaccine Excipients Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Vaccine Excipients Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Vaccine Excipients in 2026
Figure 74. Manufacturing Process Analysis of Vaccine Excipients
Figure 75. Industry Chain Structure of Vaccine Excipients
Figure 76. Channels of Distribution
Figure 77. Global Vaccine Excipients Sales Market Forecast by Region (2027-2032)
Figure 78. Global Vaccine Excipients Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Vaccine Excipients Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Vaccine Excipients Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Vaccine Excipients Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Vaccine Excipients Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Vaccine Excipients
Figure 2. Vaccine Excipients Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vaccine Excipients Sales Growth Rate 2021-2032 (kg)
Figure 7. Global Vaccine Excipients Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Vaccine Excipients Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Vaccine Excipients Sales Market Share by Country/Region (2025)
Figure 10. Vaccine Excipients Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Vaccine Stabilizers
Figure 12. Product Picture of Vaccine Emulsifiers
Figure 13. Product Picture of Vaccine Adjuvants
Figure 14. Product Picture of Preservatives
Figure 15. Global Vaccine Excipients Sales Market Share by Type in 2026
Figure 16. Global Vaccine Excipients Revenue Market Share by Type (2021-2026)
Figure 17. Vaccine Excipients Consumed in Research Applications
Figure 18. Global Vaccine Excipients Market: Research Applications (2021-2026) & (kg)
Figure 19. Vaccine Excipients Consumed in Commercial Applications
Figure 20. Global Vaccine Excipients Market: Commercial Applications (2021-2026) & (kg)
Figure 21. Global Vaccine Excipients Sale Market Share by Application (2025)
Figure 22. Global Vaccine Excipients Revenue Market Share by Application in 2026
Figure 23. Vaccine Excipients Sales by Company in 2026 (kg)
Figure 24. Global Vaccine Excipients Sales Market Share by Company in 2026
Figure 25. Vaccine Excipients Revenue by Company in 2026 ($ millions)
Figure 26. Global Vaccine Excipients Revenue Market Share by Company in 2026
Figure 27. Global Vaccine Excipients Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Vaccine Excipients Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Vaccine Excipients Sales 2021-2026 (kg)
Figure 30. Americas Vaccine Excipients Revenue 2021-2026 ($ millions)
Figure 31. APAC Vaccine Excipients Sales 2021-2026 (kg)
Figure 32. APAC Vaccine Excipients Revenue 2021-2026 ($ millions)
Figure 33. Europe Vaccine Excipients Sales 2021-2026 (kg)
Figure 34. Europe Vaccine Excipients Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Vaccine Excipients Sales 2021-2026 (kg)
Figure 36. Middle East & Africa Vaccine Excipients Revenue 2021-2026 ($ millions)
Figure 37. Americas Vaccine Excipients Sales Market Share by Country in 2026
Figure 38. Americas Vaccine Excipients Revenue Market Share by Country (2021-2026)
Figure 39. Americas Vaccine Excipients Sales Market Share by Type (2021-2026)
Figure 40. Americas Vaccine Excipients Sales Market Share by Application (2021-2026)
Figure 41. United States Vaccine Excipients Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Vaccine Excipients Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Vaccine Excipients Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Vaccine Excipients Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Vaccine Excipients Sales Market Share by Region in 2026
Figure 46. APAC Vaccine Excipients Revenue Market Share by Region (2021-2026)
Figure 47. APAC Vaccine Excipients Sales Market Share by Type (2021-2026)
Figure 48. APAC Vaccine Excipients Sales Market Share by Application (2021-2026)
Figure 49. China Vaccine Excipients Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Vaccine Excipients Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Vaccine Excipients Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Vaccine Excipients Revenue Growth 2021-2026 ($ millions)
Figure 53. India Vaccine Excipients Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Vaccine Excipients Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Vaccine Excipients Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Vaccine Excipients Sales Market Share by Country in 2026
Figure 57. Europe Vaccine Excipients Revenue Market Share by Country (2021-2026)
Figure 58. Europe Vaccine Excipients Sales Market Share by Type (2021-2026)
Figure 59. Europe Vaccine Excipients Sales Market Share by Application (2021-2026)
Figure 60. Germany Vaccine Excipients Revenue Growth 2021-2026 ($ millions)
Figure 61. France Vaccine Excipients Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Vaccine Excipients Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Vaccine Excipients Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Vaccine Excipients Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Vaccine Excipients Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Vaccine Excipients Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Vaccine Excipients Sales Market Share by Application (2021-2026)
Figure 68. Egypt Vaccine Excipients Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Vaccine Excipients Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Vaccine Excipients Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Vaccine Excipients Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Vaccine Excipients Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Vaccine Excipients in 2026
Figure 74. Manufacturing Process Analysis of Vaccine Excipients
Figure 75. Industry Chain Structure of Vaccine Excipients
Figure 76. Channels of Distribution
Figure 77. Global Vaccine Excipients Sales Market Forecast by Region (2027-2032)
Figure 78. Global Vaccine Excipients Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Vaccine Excipients Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Vaccine Excipients Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Vaccine Excipients Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Vaccine Excipients Revenue Market Share Forecast by Application (2027-2032)
